Carfilzomib is a novel proteasome inhibitor employed in the fight against cancer. This treatment operates by blocking the activity of the proteasome, a cellular complex responsible for the degradation of proteins. By https://delilahoffg206438.blog5.net/91854131/carfilzomib-pr-171-a-novel-proteasome-inhibitor-in-cancer-therapy